Joffrey Feriel: Comprehensive Review of Laboratory Assays for von Willebrand Factor and Associated Disorders
Joffrey Feriel, Associate director of medical affairs at STAGO, shared a post on LinkedIn about recent articles by François Depassea et al, adding:
“A myriad of laboratory assays, from first line to esoteric assays, exist to enable adequate diagnosis of VWD and other diseases influenced by VWF.
Choosing the right test for the right situation can be tedious and DIN members are helping us with this task by publishing two excellent review articles.
The first article provides a comprehensive overview of all relevant assays with their technical features, analytical performance and availability for research and clinical purposes.
The second article focuses on the use of these assays for the diagnosis of VWD, acquired von Willebrand syndrome, and for thrombotic risk assessment.
Congratulations to Francois Depasse, Nikolaus B. Binder, Mariona Bono Illa, Matthias Germer, Michael Heins, Martina Leplatoni, Patzke Juergen, Stephan Schwers, Michael Spannagl, Peter L. Turecek.”
Title: Review of laboratory methods used for analysis of von Willebrand factor and for diagnosis of related diseases
Authors: Jürgen Patzke, Nikolaus B Binder, Mariona Bono, François Depasse, Matthias Germer, Michael Heins, Martina Leplatoni, Stephan Schwers, Michael Spannagl, Peter L Turecek
Read the Full Article on Expert Review of Hematology.
Title: Von Willebrand factor is a multifaceted player in hemostasis requiring a diverse array of analytical and diagnostic approaches
Authors: François Depasse, Nikolaus B. Binder, Mariona Bono, Matthias Germer, Michael Heins, Martina Leplatoni, Jürgen Patzke, Stephan Schwers, Michael Spannagl, Peter L. Turecekb
Read the Full Article on Expert Review of Hematology.
Stay updated on all scientific advances with Hemostasis Today.
-
May 24, 2026, 13:46Sergio Emanuel Kaiser: A Whole New Array of Potent Oral PCSK9 Inhibitors
-
May 24, 2026, 13:10Thomas Pincez: Emerging Challenges in Sickle Cell Disease Gene Therapy and Cancer Risk
-
May 24, 2026, 12:04Kalpana Gupta Shekhawat: Ferritin Is More Than an Iron Marker
-
May 24, 2026, 11:50Peter Zdziarski: Making Rare Disease Research More Human
-
May 24, 2026, 11:39Bram Berkelmans: Donating with a View
-
May 24, 2026, 11:28Ratiporn Chinthammit: A Meaningful Exchange in aHUS and PNH Education
-
May 24, 2026, 11:17Mary Ann Sromoski: Transfusion Medicine and Patient Blood Management in Practice
-
May 24, 2026, 07:45Thierry Burnouf: Advances in Platelet Membrane-Coated Nanoparticles for Targeted Therapeutics and Regenerative Medicine
-
May 24, 2026, 07:39Shamala Thilarajah: Our Team Receives the NMRC Transition Award for NEUROACT-Stroke